281 related articles for article (PubMed ID: 20203164)
1. Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.
Markowitz GS; Nasr SH; Stokes MB; D'Agati VD
Clin J Am Soc Nephrol; 2010 Apr; 5(4):607-15. PubMed ID: 20203164
[TBL] [Abstract][Full Text] [Related]
2. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS.
Laurin LP; Gasim AM; Derebail VK; McGregor JG; Kidd JM; Hogan SL; Poulton CJ; Detwiler RK; Jennette JC; Falk RJ; Nachman PH
Clin J Am Soc Nephrol; 2016 Oct; 11(10):1752-1759. PubMed ID: 27445167
[TBL] [Abstract][Full Text] [Related]
3. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
Yokoyama H; Sugiyama H; Narita I; Saito T; Yamagata K; Nishio S; Fujimoto S; Mori N; Yuzawa Y; Okuda S; Maruyama S; Sato H; Ueda Y; Makino H; Matsuo S
Clin Exp Nephrol; 2015 Jun; 19(3):496-505. PubMed ID: 25230687
[TBL] [Abstract][Full Text] [Related]
5. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB; Markowitz GS; Lin J; Valeri AM; D'Agati VD
Kidney Int; 2004 May; 65(5):1690-702. PubMed ID: 15086908
[TBL] [Abstract][Full Text] [Related]
6. Tip variant focal segmental glomerulosclerosis associated with interferon-β treatment of multiple sclerosis.
Evans R; Rudd P; Bass P; Harber M
BMJ Case Rep; 2014 Feb; 2014():. PubMed ID: 24503666
[No Abstract] [Full Text] [Related]
7. Idiopathic collapsing glomerulopathy in children.
Gulati A; Sharma A; Hari P; Dinda AK; Bagga A
Clin Exp Nephrol; 2008 Oct; 12(5):348-353. PubMed ID: 18392736
[TBL] [Abstract][Full Text] [Related]
8. Focal segmental glomerulosclerosis with acute renal failure associated with alpha-interferon therapy.
Coroneos E; Petrusevska G; Varghese F; Truong LD
Am J Kidney Dis; 1996 Dec; 28(6):888-92. PubMed ID: 8957041
[TBL] [Abstract][Full Text] [Related]
9. Development of focal segmental glomerulosclerosis after anabolic steroid abuse.
Herlitz LC; Markowitz GS; Farris AB; Schwimmer JA; Stokes MB; Kunis C; Colvin RB; D'Agati VD
J Am Soc Nephrol; 2010 Jan; 21(1):163-72. PubMed ID: 19917783
[TBL] [Abstract][Full Text] [Related]
10. Association of histologic variants in FSGS clinical trial with presenting features and outcomes.
D'Agati VD; Alster JM; Jennette JC; Thomas DB; Pullman J; Savino DA; Cohen AH; Gipson DS; Gassman JJ; Radeva MK; Moxey-Mims MM; Friedman AL; Kaskel FJ; Trachtman H; Alpers CE; Fogo AB; Greene TH; Nast CC
Clin J Am Soc Nephrol; 2013 Mar; 8(3):399-406. PubMed ID: 23220425
[TBL] [Abstract][Full Text] [Related]
11. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.
Valeri A; Barisoni L; Appel GB; Seigle R; D'Agati V
Kidney Int; 1996 Nov; 50(5):1734-46. PubMed ID: 8914044
[TBL] [Abstract][Full Text] [Related]
13. Focal and segmental glomerulosclerosis: does prognosis vary with the variants?
Swarnalatha G; Ram R; Ismal KM; Vali S; Sahay M; Dakshinamurty KV
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):173-81. PubMed ID: 25579744
[TBL] [Abstract][Full Text] [Related]
14. Repository corticotropin injection versus corticosteroids for protection against renal damage in a focal segmental glomerulosclerosis rodent model.
Hayes K; Warner E; Bollinger C; Wright D; Fitch RM
BMC Nephrol; 2020 Jun; 21(1):226. PubMed ID: 32539845
[TBL] [Abstract][Full Text] [Related]
15. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C.
Rostaing L; Modesto A; Baron E; Cisterne JM; Chabannier MH; Durand D
Nephron; 1996; 74(3):512-6. PubMed ID: 8938673
[TBL] [Abstract][Full Text] [Related]
16. Focal segmental glomerulosclerosis associated with nephrotic syndrome in cholesterol atheroembolism: clinicopathological correlations.
Greenberg A; Bastacky SI; Iqbal A; Borochovitz D; Johnson JP
Am J Kidney Dis; 1997 Mar; 29(3):334-44. PubMed ID: 9041208
[TBL] [Abstract][Full Text] [Related]
17. Duration of optimal therapy for idiopathic focal segmental glomerulosclerosis.
Pokhariyal S; Gulati S; Prasad N; Sharma RK; Singh U; Gupta RK; Mittal S; Mehta B
J Nephrol; 2003; 16(5):691-6. PubMed ID: 14733415
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis.
Alexopoulos E; Stangou M; Papagianni A; Pantzaki A; Papadimitriou M
Nephrol Dial Transplant; 2000 Sep; 15(9):1348-56. PubMed ID: 10978390
[TBL] [Abstract][Full Text] [Related]
19. Collapsing Lesions and Focal Segmental Glomerulosclerosis in Pregnancy: A Report of 3 Cases.
Orozco Guillén OA; Velazquez Silva RI; Gonzalez BM; Becerra Gamba T; Gutiérrez Marín A; Paredes NR; Cardona Pérez JA; Soto Abraham V; Piccoli GB; Madero M
Am J Kidney Dis; 2019 Dec; 74(6):837-843. PubMed ID: 31378644
[TBL] [Abstract][Full Text] [Related]
20. Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.
Detwiler RK; Falk RJ; Hogan SL; Jennette JC
Kidney Int; 1994 May; 45(5):1416-24. PubMed ID: 8072254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
